Oestrogens have a major impact on reproductive function in both males and females. Two oestrogen receptor genes known as ER (ESR1NR3A1) and ER (ESR2NR3A2) have been cloned. Splice variant isoforms of the ER gene have been identified in human, bovine and rodents and it has been suggested that the existence of these forms can influence oestrogen responsiveness. In the human, splicing of an alternative eighth exon results in the formation of a C-terminal variant called hER cx, or hER 2, but this isoform has not been identified in other species. The aim of the present study was to clone ER cDNAs from primates so as to determine how closely they resembled the ER isoforms found in the human. The two species studied were the stump-tailed macaque (Macaca arctoides), an Old World primate, and the common marmoset (Callithrix jacchus jacchus), a New World primate.
Introduction
Oestrogen action is mediated via specific receptors (ER). The first oestrogen receptor was cloned from a human breast cancer cell line in 1986 (Green et al. 1986) . In 1996, a second ER was cloned from rat (Kuiper et al. 1996) and human (Mosselman et al. 1996) tissues. The two receptors are known as oestrogen receptor alpha (ER , ESR1NR3A1) and oestrogen receptor beta (ER , ESR2NR3A2) respectively. Evolutionary studies have suggested that the vertebrate steroid receptors evolved from an ancestral receptor with oestrogen receptor-like function by serial genome expansion (Thornton 2001 , Thornton et al. 2003 . Human (h) ER and hER contain significant sequence homology and are classified as subgroup A of the nuclear receptor subfamily 3 (Nuclear Receptors Nomenclature Committee 1999). They are the products of two genes located on different chromosomes and phylogenetic analysis suggests that they arose from a single duplication event at least 450 million years ago (Kelley & Thackray 1999) .
ER and ER both bind to a range of oestrogenic ligands although they exhibit different affinities for some ligands notably genistein, raloxifene and tamoxifen , Barkhem et al. 1998 . Key domains within ER and ER include the DNA binding domain (C) and two transactivation domains (AF-1 and AF-2) located in the N (A/B domain) and C terminal (E/F domain) portions of the protein respectively (see reviews by Saunders 1998 and Nilsson et al. 2001) . The crystal structures of the ligand binding domains of ER and ER have been determined and their overall arrangement shown to be similar, both containing 12 helices (Pike et al. 1999) . In vitro studies have demonstrated that homodimers (ER -ER or ER -ER ), or heterodimers (ER -ER ), can be formed when both isoforms are expressed in the same cell (Cowley et al. 1997 , Pettersson et al. 1997 . Results obtained from in vitro and in vivo studies have suggested that one role played by ER may be to modulate ER -mediated transcriptional activity (Hall & McDonnell 1999 , Weihua et al. 2000 .
Splice variant isoforms of the ER gene have been identified in a number of species including the human (Lu et al. 1998 , Moore et al. 1998 , Ogawa et al. 1998b , Inoue et al. 2000 , the bovine (Walther et al. 1999 ) and rodents (Chu & Fuller 1997 , Lu et al. 1998 . One striking feature revealed by sequencing of these products is that the variant most commonly found in rodent tissues, formed by an insertion of 18 amino acids within the ligand binding domain (Chu & Fuller 1997 , Pettersson et al. 1997 , has not been detected in human tissue extracts (Chu et al. 2000; authors' unpublished observations) . Furthermore, the extensive splicing of alternative exons at the 3 end of the human ER gene which results in formation of a number of C-terminal variants (Moore et al. 1998) has not been reported for other species.
We have previously examined the expression of ER proteins using a polyclonal antibody directed against the hinge (D) domain of hER as well as monoclonal antibodies specific for hER wild type protein (ER 1) and two of the hER C-terminal splice variants (ER 2, also know as ER cx, and ER 4 (Moore et al. 1998 , Ogawa et al. 1998b ). In human tissues immunopositive staining of cell nuclei has been reported using all these antibodies , 2001 , Critchley et al. 2002 , Scobie et al. 2002 . In addition using the polyclonal antibody, ER protein has also been detected in tissues from a wide range of species including primates and rodents , 2001 . Western blot analysis has shown that this antibody will bind to both hER 1 and hER 2 recombinant proteins. Immunohistochemistry using the monoclonal antibody specific for the C-terminus of hER 1 results in detection of ER protein in granulosa cells of the primate ovary but we have not previously investigated whether an ER 2 variant protein is expressed in the primates.
The aim of this study was to determine whether ER splice variant isoforms which resemble those of the human exist in closely related mammalian species. We therefore cloned ER cDNAs from two primates, namely the stump-tailed macaque (Macaca arctoides), an Old World primate, and the common marmoset (Callithrix jacchus jacchus), a New World primate, estimated to have diverged from the human line 25-27 and 30-35 million years ago respectively.
Materials and methods

Human and primate tissues
Marmoset tissues were collected from adult captive bred animals (n=5) maintained in a colony that has been closed since 1973. Testes with epididymes attached were also obtained from three adult stump-tailed macaques that were being surgically castrated under general anaesthesia for colony management purposes. These samples were the same as those used in previous studies (Saunders et al. 2001) . Additional blocks of fixed tissues were from an archive held at the Human Reproductive Sciences Unit. Sections of human endometrium were a gift from Professor Hilary Critchley (University of Edinburgh).
Immunohistochemistry
Antibodies directed against C-terminal peptides specific for hER 1 and hER 2 (hER cx) were raised as described previously (Saunders et al. , 2002a . The specificity of these antibodies has been validated using Western blotting with recombinant proteins and tissue extracts (Critchley et al. 2002 , Saunders et al. 2002a . Immunohistochemistry was performed according to standard procedures described previously in detail (Saunders et al. , 2001 (Saunders et al. , 2002a . Briefly, all sections were subjected to heat-induced antigen retrieval. Anti-hER 1 (clone PPG5/10, code MCA1974S; Serotec, Oxford, UK) was diluted 1:100 and anti-ER 2 (clone 57/3) was diluted 1:40 in NRS/TBS/BSA. Sections were incubated with the primary antibody overnight at 4 C, washed with TBS and incubated with the secondary antibody (rabbit anti-mouse, Dako, Ely, Cambs, UK) diluted 1:500 in NRS/TBS/BSA for 1 h at room temperature. Following washes in TBS, sections were incubated with avidin-biotin-horseradish peroxidase linked complex (Dako,) and bound antibodies were visualised using 3,3 -diaminobenzidine tetrahydrochloride (DAB, Dako). Images were captured using an Olympus Provis microscope (Olympus Optical Co, London, UK) equipped with a Kodak DCS330 camera (Eastman Kodak Co., Rochester, NY, USA) and assembled using Photoshop 6 (Adobe, Mountain View, CA, USA).
Synthesis of complementary cDNAs
Frozen tissue samples (ovary, testis or epididymis) were ground up under liquid nitrogen using a pestle and mortar, divided into approximately 50 mg samples, and stored at 70 C. RNA was extracted using Tri Reagent (Sigma, Poole, Dorset, UK) according to the manufacturer's instructions, dissolved in RNAse-free water, and 5 µg total RNA were subjected to reverse transcription using Expand Reverse Transcriptase (Roche, Lewes, East Sussex, UK) and an oligo dT primer. cDNAs were purified by heating to 100 C for 5 min, followed by RNase treatment at 37 C for 15 min and finally by passing through a High Pure PCR Purification column (Roche) and were quantified on a Pharmacia Biotech Genequant (St Albans, Herts, UK). All samples were adjusted to a final concentration of 5 ng/µl in TE buffer (10 mM Tris/HCl pH 7·5, 1 mM EDTA).
Screening of cDNAs using primers specific for the C terminus of ER 1 and ER 2
Complementary DNAs prepared from human, macaque and marmoset tissues were used in PCR reactions containing AGS Gold Taq (Hybaid, Ashford, Middlesex, UK). The sense primer which was located in exon 7 (hER s; 5 -GGCATCTTCCTCCCAGCAGCA) annealed to both hER 1 (AB006590 starting at position 1432) and hER cx/2 (AB006589 starting at position 2608). This primer was used in conjunction with one of two antisense primers which were specific for hER 1 (antisense strand, 5 -CACT GAGACTGTGGGTTCTGGGA, ends at 1691, expected size 259 bp) and hER 2 (antisense strand, 5 -CACTGCTCCATCGTTGCTTC, ends at 2762, expected size 155 bp). Control reactions to ensure that intact cDNA was present contained 
Amplification of full length ER 1 and ER 2 cDNAs
Full length cDNAs were amplified from cDNA pools using primers homologous to human ER sequences 5 of the ATG start (sense) and 3 of the TGA stop (antisense). Primer pairs (designated as ER 1L and ER 2L) are given in Table 1 . PCR conditions were the same as those used above except that the annealing temperature was reduced to 55 C and the extension time increased to 1 min 30 s. PCR products were purified through a Clontech 400 column (BD Biosciences, Cowley, Oxon, UK) and directly sequenced using the primers used for PCR amplification as well as internal sequencing primers homologous to hER (Table 1) . To control for introduction of sequence changes from PCR amplification, the reactions were conducted several times on cDNAs prepared from more than one tissue on more than one occasion; a consensus sequence was determined by multiple alignment.
Preparation of ER 1/ER 2 expression constructs
ER 1 and ER 2 cDNAs generated from all three species using the 'long' primer pair were cloned into the TA cloning site of the eukaryotic expression vector pCDNA3·1/V5-His (Invitrogen, Paisley, Strathclyde, UK) according to the manufacturer's instructions. This plasmid was chosen because it contains a T7 RNA polymerase site upstream of the insertion site and can therefore be used for in vitro synthesis of proteins. The plasmids were sequenced fully and purified using caesium chloride according to standard methods.
Transcription/translation analysis of cloned cDNAs (TNT)
Purified pCDNA 3·1 plasmids (1 µg each) were added to separate tubes containing 50 µl T7 coupled reticulocyte lysate (TNT, Promega, Southampton, UK) in the presence of 20 µCi 35 S-methionine (Amersham, Little Chalfont, Bucks, UK). Transcription coupled translation was allowed to proceed for 90 min at 30 C. Expressed proteins (2·5 µl of each lysate) were separated on a 4-20% denaturing gradient gel (Invitrogen) and visualised by direct exposure of the gel to X-ray film (XLS, Kodak).
Oestrogenic ligands
17 -Oestradiol (E-8875), 5-alpha-androstane-3-beta, 17 -diol (Adiol; A-7630) and 4 ,5,7-trihydroxyisoflavone (Genistein; G-6649) were all purchased from Sigma. DPN and PPT were purchased from Tocris Cookson Ltd (Avonmouth, Bristol, UK). DPN (2,3-bis(4-hydroxyphenyl)-propionitrile) is marketed as an ER agonist with a 70-fold selectivity over ER (Meyers et al. 2001) .
is marketed as an ER agonist and is reported to exhibit 410-fold selectivity for ER over ER (Stauffer et al. 2000) . All ligands were reconstituted in ethanol (100% v/v) apart from genistein which was dissolved in DMSO; all stocks were stored at 20 C.
Transient transfections
Hep G2 cells (human hepatocellular carcinoma, ECACC; Health Protection Agency, Porton Down, UK) were maintained in DMEM phenol red-free medium (Sigma) supplemented with 10% charcoalstripped fetal bovine serum (GIBCO, Paisley, Strathclyde, UK), -glucose (Sigma), -glutamate (Sigma), non-essential amino acids (Ambion, Abingdon, Oxon, UK), fungizone (GIBCO) and penicillin-streptomycin (Sigma). Cells were plated out into 12-well plates (Corning, Fisher Scientific, Loughborough, Leics, UK) at a density of 1 10 5 cells per ml media 24 h prior to transfection. Human ER was obtained as a full length cDNA in a PIC OH plasmid (ATCC, LGC Promochem, Teddington, Middx, UK) and subcloned into pcDNA3·1 using BamHI and EcoRV restriction sites. ER 1 and ER 2 expression vectors were prepared as above. A reporter construct containing 3 vitellogenin oestrogen response element (ERE)-linked to TK-luciferase was a kind gift from S C Nagel and D P McDonnell (Hall & McDonnell 1999) . In each well, cells were co-transfected with 1 µg ER, 0·5 µg 3 ERE-luciferase reporter and 100 ng Renilla cytomegalovirus (CMV) internal control; to introduce the DNA into the cells they were incubated for 4 h with JetPEI transfection reagent (Cambridge Biosciences, Cambridge, Cambs, UK) and the DNA mix. Ligands or vehicle (ethanol) were added and cells were incubated for a further 24 h before the medium was replaced with fresh medium containing the appropriate ligand for a further 24 h. Cells were harvested and assayed using a luciferase assay kit from Promega. Results were normalised against the Renilla internal control, and the amount of luciferase activity obtained in the absence of ligand (ethanol alone) was designated as 1; all results were expressed as a fold increase relative to the value obtained in the ligand-free control present in each experiment. All treatments were performed in duplicate wells and experiments repeated at least 3 times. Results are presented as the mean S.D. of the fold changes seen in the individual experiments.
Results
Detection of ER 1 and ER 2 mRNAs in samples from multiple human and primate tissues
RT-PCR analysis using hER 1-and hER 2-specific primer pairs resulted in amplification of DNA from ovaries, testes and epididymes from marmoset and from testes and epididymes from macaque ( Fig. 1) . The sizes of the amplified DNAs were identical to those from human ovaries and testes which were used as positive controls (Fig. 1) ; no reaction product was seen in negative control samples lacking cDNA. In a more extensive comparison of tissues from human and marmoset the pattern of expression of mRNAs was identical in both species: ER 1 and ER 2 (heart, ovary, testis), ER 1 alone (brain, liver, placenta), neither transcript (kidney). Preliminary sequence analysis confirmed that the DNA fragments from marmoset and macaque were homologous to hER 1 and hER 2 (not shown).
Immunohistochemistry using hER 1-and hER 2-specific monoclonal antibodies
Consistent with the identification of ER 1 mRNAs in primate tissue extracts and with previous immunohistochemical data , ER 1 protein was immunolocalised to endometrium ( Fig. 2a-c) and testes ( Fig. 2g-i ) from human, macaque and marmoset using a monoclonal antibody specific for the C-terminus of hER 1. However, when staining reactions were undertaken on the same tissue panel using an hER 2-specific antibody, staining was only detected in human tissues (Fig. 2d, j) and no immunopositive reaction was detected in any of the primate tissues examined (Fig. 2e, f , k, i, and unpublished observations).
Sequence analysis of full length cDNAs encoding ER 1 and ER 2 variants in macaque and marmoset
Double stranded DNA of the expected sizes were amplified from macaque and marmoset cDNA pools using primers located upstream of the ATG in human ER and downstream of the stop site in either hER 1 or hER 2/ cx (accession no. NM_001437). The nucleotide sequences obtained have been lodged in Genbank (accession nos Y09372, AF393816, AF393815). The peptide sequences predicted from the open reading frames of the ER 1 cDNAs from macaque and marmoset are compared in Fig. 3A . Note that there is a high degree of sequence conservation with 97·5% (517/530) homology between macaque and human and 93·8% (497/530) homology between marmoset and human. In two positions (amino acids 341 and 478) identical amino acid substitutions were present in macaque and marmoset but all other changes were different in the two species. The sequence homology within the peptide used to raise the ER 1-specific monoclonal antibody (underlined at the C-terminus of hER 1) was 18/19 and 17/19 for macaque and marmoset respectively compared with human.
A full length protein of 486 amino acids was predicted from the open reading frame (ORF) of the marmoset ER 2 cDNA (C-terminal portion Figure 2 Immunohistochemical evaluation of ER 1 and ER 2 expression in endometrium and testes from human, macaque and marmoset using variant-specific monoclonal antibodies. Sections from human (a, d, g, j) , macaque (b, e, h, k) and marmoset (c, f, i, l) were stained with hER 1-or hER 2-specific monoclonal antibodies. Positive staining of cell nuclei was observed for ER 1 in endometrium (a-c) and testes (g-i) from all three species. However when the same tissues were stained for ER 2 only human endometrium (d) and testis (j) were immunopositive.
of protein illustrated in Fig. 3B ). Comparison with human ER 2 showed 91·1% amino acid conservation (451/495); however the protein was slightly shorter than the human protein and the peptide sequence used to raise the human ER 2-specific monoclonal (underlined in Fig. 3B ) was not conserved in the marmoset. Although a cDNA of comparable size to hER 2 was amplified from macaque cDNA pools, sequence analysis revealed that it included an additional 56 bp of sequence which was homologous to sequences at the 5 end of intron 4 in the human ER gene sequence. The inclusion of this intronic sequence resulted in the introduction of an in-frame stop codon resulting in a predicted ORF of 321 amino acids. Extensive analysis of multiple clones from several macaque tissues did not result in isolation of any cDNAs lacking this intronic sequence.
Analysis of recombinant proteins prepared by in vitro translation
Proteins corresponding to both the long (59 kDa, Ogawa et al. 1998a ) and short (54 kDa, (Mosselman et al. 1996) forms of hER 1 were translated from the human cDNAs (Fig. 4 lane 1) consistent with Western data showing that both AUG start sites are functional in vivo (Saunders et al. 2002b ). Plasmids containing ER 1 cDNAs isolated from marmoset and macaque generated proteins of a similar size to hER 1 (Fig. 4 lanes 3, 5, 6 ). Proteins synthesised from hER 2-containing plasmids were smaller (55·5 kDa and 50·5 kDa) than those of hER 1, consistent with the use of alternative AUG starts and the incorporation of an alternative terminal coding exon with a shorter ORF than that of hER 1. Translation of ER 2 cDNAs from marmoset and macaque resulted in synthesis of proteins of 54·3 kDa (lane 4) and 35·8 kDa (lanes 7 and 8) respectively. In macaque, a second prominent protein band was detected at 30 kDa and this would be consistent with the use of the alternative AUG resulting in a protein lacking 54 amino acids at the amino terminus.
Reporter gene activation in transient transfection assays
Incubation of cells co-transfected with an ERE reporter and hER or hER 1 (wild type, WT) with increasing concentrations of oestradiol (Fig. 5) resulted in a ligand-dependent induction of reporter gene expression. Consistent with previous reports, ER was able to induce four-to fivefold higher levels of reporter gene expression than ER 1 at equivalent ligand concentrations (Table 2) . Activation of the reporter gene by ER 1-containing constructs was similar for human, macaque and marmoset (Fig. 5) , although the marmoset ER 1 was slightly more active than its human homologue at higher concentrations of oestradiol (10 7 , 10 6 M). Consistent with the absence of a functional AF-2 domain in hER 2, the protein did not activate ERE-luciferase reporter gene expression in the presence of any of the ligands tested (e.g. oestradiol, Fig. 5 (hER 2) ). When incubated with increasing concentrations of PPT, activation of the ERE reporter by the ER 1-containing constructs (Fig. 6 ) was minimal compared with that observed using the hER -positive control (Fig. 6 ) and only the macaque ER 1 showed any activity although this was approximately 12-fold lower than hER even at 10 6 M ligand concentration (Table 2 ). DPN is marketed as an ER selective agonist and at concentrations between 10 9 and 10 7 M ERE reporter activation by human, macaque and marmoset ER 1-containing constructs was greater than that seen with hER (Fig. 6) . However, at higher concentrations of ligand (i.e. 10 6 to 10 4 M) DPN was able to act as a potent agonist for hER . Identical reporter gene activation assays were carried out in the presence of Adiol and genistein and the results obtained are compared with those from incubations with oestradiol, PPT and DPN in Table 2 .
Discussion
The aim of the current study was to establish whether wild type and variant ER proteins in primate species share significant sequence homology with those from the human. We have previously detected ER protein expression in tissues from these primate species using immunohistochemistry with an antibody directed against the hinge domain of human ER (Saunders et al. , 2001 . A comparison of the ER 1 and ER 2 proteins identified in this study is presented in Fig. 7 . It is notable that in both an Old World and a New World primate not only did the ER 1 proteins share significant sequence homology with hER , but variant mRNAs homologous to hER 2 (also known as hER cx) were identified. This splice variant isoform has not previously been identified in other species and its existence in primates would suggest that the mechanisms that control the alternative splicing of the eighth coding exon of the ER gene evolved at, or before, the divergence of the New World primates from the human line approximately 35 million years ago. We have not found any evidence in these, or other unpublished studies, for the existence of a variant equivalent to the rodent ER 2 variant (Chu & Fuller 1997 , Petersen et al. 1998 in human or primate tissues, a finding in agreement with other investigators who have also failed to detect hER 2 homologues in rodents (Chu et al. 2000) . Further studies are needed to determine if the inclusion of intronic sequences such as those seen in the macaque are replicated in other species. Interestingly, studies on the organisation of spermatogenesis in primate species have revealed that the marmoset more closely resembles the human than does the macaque , Wistuba et al. 2003 .
Sequence comparisons between the peptides predicted from the open reading frames of the ER 1 and ER 2 cDNAs from the macaque and marmoset with the hER 1 and hER 2 proteins solved the apparent conflict between results obtained with RT-PCR and immunohistochemistry. Although sequences homologous to the peptide used to raise the anti-hER 1 monoclonal were identified in the ER 1 sequences isolated from both primates, this was not the case when ER 2 protein sequences were analysed. In vitro transcription/translation revealed that in the primate species, as well as in the human, more than one size of protein was generated from the full length cDNAs and that their sizes were consistent with the use of two different AUG start sites as previously documented (Ogawa et al. 1998a , Tremblay et al. 1999 . We have shown that ER 1 proteins with sizes identical to long (59 kDa) and short (54 kDa) recombinant hER can be extracted from human breast cancers (Saunders et al. 2002b) consistent with induction of translation at both AUGs in vivo. Inoue et al. (2000) cloned and sequenced a splice variant isoform of hER that lacked exon 5 and showed that this was able to act as a dominant negative inhibitor of ER -and ER 1-induced gene activation. We (Critchley et al. 2002 , Scobie et al. 2002 ; present study) and others (Speirs et al. 2000 , Poola et al. 2002a ) have reported the expression of exon 5-deleted mRNAs in normal and malignant tissues and cell lines. It is notable that the cDNA for the macaque ER 2 contained a portion of intron 4 consistent with the activation of a cryptic splice site, suggesting that the exon 4/intron 4 splice site is particularly susceptible to alternative splice site selection. Although multiple cDNA pools were analysed from several tissues we never identified a macaque ER 2 cDNA that lacked this intronderived sequence. The macaque ER 2 proteins generated in vitro from the cDNA clones migrated with apparent molecular masses of 35 and 30 kDa on acrylamide gels and it is notable that in previous studies using protein extracts from macaque tissues, proteins of similar size were identified on Western blots (see Fig. 4 in Saunders et al. 2001) . Because the antibodies directed against hER 2 did not cross-react with the ER 2 proteins identified in either of the primates, a direct comparison between the pattern of expression of hER 2 and primate ER 2 proteins using Western analysis or immunohistochemistry will require development of new antibody reagents.
Functional studies were carried out using transient co-transfection of ER-containing constructs and a luciferase reporter gene driven by a promoter made up of three copies of the vitellogenin ERE. This reporter has been used extensively to investigate the ability of oestrogens to activate ER and ER and is strongly induced by ER in the presence of a range of oestrogens and xenoestrogens (Hall & McDonnell 1999 , Hall & Korach 2002 . Consistent with previous reports (Ogawa et al. 1998b , Peng et al. 2003 ) ER 2-containing constructs were unable to activate reporter gene expression in the presence of oestradiol. All the ER 2 proteins identified lacked the core AF-2 domain (see Fig. 7 ), which is located in helix 12 of ER and ER 1 (Tanenbaum et al. 1998 ), but contain sequences essential for dimerisation and DNA binding (Lees et al. 1990) .
The functional significance of the expression of ER 2 and other ER splice variants in human cell lines and tissues has been investigated in a number of ways. Using gel-shift analysis, Moore et al. (1998) demonstrated that ER 1 (WT) and ER 2 could form homo-and heterodimers. From transient co-transfection studies, there is evidence that hER 2 can act as a dominant negative suppressor of oestrogen-activated hER -mediated gene activation in vitro (Ogawa et al. 1998b , Peng et al. 2003 . ER variant mRNAs have been detected in a range of malignant tissues including breast cancers (Poola et al. 2002b) , and in support of the idea that ER 2 may act as a dominant negative 'receptor' it has been reported that co-expression of ER and ER 2 is associated with reduced expression of progesterone receptor in breast cancer specimens (Saji et al. 2002) . Our studies showing that the marmoset contains an ER splice variant with close homology to hER 2 as well as an exon 5-deleted variant mRNA means this species may provide a suitable animal model in which to assess the impact of the expression of ER variants on tissue responsiveness to oestrogens.
Detailed structural analysis of ER proteins bound to agonists and antagonists has provided clues as to the way(s) in which these ligands influence co-factor recruitment by altering the position adopted by helix 12 (Brzozowski et al. 1997 , Shiau et al. 1998 . Although amino acids corresponding to helix 12 in human ER (488 to 499) (Pike et al. 1999) are fully conserved in macaque ER 1, in the marmoset leucine 495 is changed to methionine. This amino acid is homologous to leucine 548 in mouse ER ; mutation of this amino acid to alanine was shown by Mahfoudi et al. (1995) to alter the responsiveness Figure 5 Impact of oestradiol on the ability of ER expression constructs to activate an ERE-luciferase reporter. Panels show human ER (note different vertical scale), hER 1, hER 2, macaque ER 1 (mcER 1) and marmoset ER 1 (maER 1). Oestradiol was added to wells in the concentration range 10 −12 to 10 −6 M. All changes in induction of the ERE-luciferase reporter construct were corrected using an internal Renilla control. Fold differences are related to the level of reporter gene expression in the absence of ligand (0). of the mutant receptor to agonists and antagonists. Both leucine and methionine are hydrophobic and this substitution may therefore have a minimal impact on the orientation of helix 12 following ligand binding. It is notable that the marmoset ER 1 was able to induce transcription of the ERE-luciferase reporter gene in vitro and we therefore assume a receptor-ligand dimer was formed and was able to recruit endogenous co-activator proteins efficiently.
Crystallographic studies have identified the amino acids within the ligand binding domains of ER and ER that line the binding cavity and contribute to ligand-specific binding (Brzozowski et al. 1997 , Tanenbaum et al. 1998 , Pike et al. 1999 . These are located in helices 3, 6, 8, 11 and 12 (Pike et al. 1999) . Comparison of the ER 1 protein sequences from human, macaque and marmoset revealed strong sequence homology and although some amino acids within the ligand binding domain were changed, most of these were not amino acids which interact directly with ligand. In several cases the amino acid encoded by the primate sequence was changed from that seen in the human sequence to the amino acid found in rat or mouse ER . Examples of this type of change in the macaque are V239, S243, T252, V341, N520 and in the marmoset S261, L325, V341, E421. Of more interest are changes that either result in substitution of an amino acid to one identical to hER and/or a change in an amino acid which is conserved between hER and hER (Pike et al. 1999) . For example, in the macaque, the amino acid at position 478 is a serine, in hER an asparagine is present in this position but hER has a serine (527). However, this substitution appears unlikely to explain why macaque ER 1 was activated by the ER selective ligand PPT slightly more efficiently than hER 1, as both rat (Pike et al. 1999) and marmoset ER 1 have a serine in this position and in the present study marmoset ER 1 did not induce reporter gene activity in the presence of PPT any more efficiently than did hER 1. Also of interest is the observation that in the marmoset a leucine is present at position 336 (changed from methionine in hER 1); the equivalent amino acid in hER is L384. In hER L384 is one of the amino acids implicated in determining the ligand binding specificity of the ligand binding pocket (Tanenbaum et al. 1998 ) but more detailed analysis would be needed to determine whether this affects the ability of marmoset ER to bind ligands.
Two of the amino acid substitutions in the marmoset ER 1 sequence are of particular note when considering ligand interactions. Both changes result in substitution of a valine (V376, V404) in place of an isoleucine which is conserved in hER , hER , rat ER and macaque ER (Pike et al. 1999) . Although both isoleucine and valine are classed as hydrophobic amino acids, valine has a shorter side chain than isoleucine. In hER isoleucine 424 (equivalent to I376 in hER ) has been implicated in contributing to the hydrophobic binding site of the receptors (Brzozowski et al. 1997) . Studies examining binding of genistein to hER concluded that I376 was one of those making contact with the bound ligand (Pike et al. 1999 ). In the current series of transient transfections maximal fold activation of the 3 vitellogenin ERE containing reporter by marmoset ER 1 in the presence of selected ligands was as good (e.g. with genistein, oestradiol) or better (e.g. Adiol, DPN) than the equivalent result obtained with hER 1, Oestradiol  11·7  15·3  12·1  14·0  17·1  18·9  59·4  68·8  Adiol  5·4  10·4  12·2  19·1  5·5  22·3  67·6  415·8  Genistein  4·9  7·9  2·8  5·3  4·8  7·3  3·7  3·9  PPT  1·2  1·4  7·1  14·4  1·2  6·4  169·1  176·2  DPN  7·8  9·6  9·1  11·7  20·1  27·5 5·3 66·3 Figure 6 Activation of ER 1 from human, macaque and marmoset following incubation with PPT or DPN. Upper panels, PPT (10 −12 to 10 −6 M); lower panels, DPN 10 −10 to 10 −4 M. Cells were transfected with plasmids containing hER (control) or ER 1 from human (hER ), macaque (mcER ) and marmoset (maER ). Note that PPT is a potent activator of ER -induced reporter gene expression but does not activate ER 1 protein from human or marmoset. DPN is marketed as an ER 1 selective agonist but at concentrations of 10 −6 M or greater it acted as an ER agonist.
suggesting that this substitution might have influenced receptor activity. However, further studies would be required before we can be sure that the ligand binding pocket has been changed in the marmoset protein.
In conclusion, we have cloned and sequenced ER cDNAs from both Old World (M. arctoides) and New World (C. jacchus jacchus) primates and have demonstrated not only that the ER 1 sequences are largely conserved but also that the alternative splicing of the eighth exon of the ER 2 gene occurs in these species as well as in the human.
Figure 7
Summary of the structure of the ER 1 and ER 2 proteins identified in human, stump-tailed macaque and common marmoset. Note that ER 1 proteins in all 3 species contain a functional AF-2 domain (486-500 in human) whereas this is absent from the full length ER 2 proteins (human, marmoset). The cDNA for the macaque contained a fragment of intronic sequence which included a stop codon (x), resulting in the synthesis of a truncated protein. Sizes given are those equivalent to the protein synthesised from the first ATG in the open reading frame.
